Confirmed. The large models have `-` (no data) in the LoRA column across all metrics. The asymmetry is clear from the paper itself. My review is accurate — proceeding to final output.

---

## Summary

This paper evaluates small LMs (≤3B parameters) and small VLMs against large, medically-adapted models (7–9B) on clinical text summarization (MeQSum) and radiology report generation (MIMIC-CXR) under zero-shot, few-shot, and PEFT (LoRA) conditions. It reports a "safety collapse" at sub-billion parameter scales and finds that small VLMs cannot match large ones even after fine-tuning.

## Strengths

1. **Practical and timely question, honestly scoped.** The paper asks whether small models can substitute for large medical LLMs in context-grounded clinical summarization, explicitly scoping out open-ended reasoning (lines 51–52). This is directly relevant to on-premise deployment, privacy, and cost.

2. **Multi-dimensional evaluation beyond n-gram metrics.** The use of MEDCON (UMLS concept coverage, line 104) alongside BLEU, ROUGE-L, and BERTScore is a genuine improvement over papers that only report surface-level overlap. The metric suite captures structural, semantic, and domain-specific quality facets.

3. **Contrast between text and vision modalities is informative.** The finding that small LMs can, under some conditions, approach large LM performance but small VLMs consistently lag (Table 4, Finding 2) is a genuinely useful result that suggests multimodal reasoning is the bottleneck, not language capability alone.

4. **The safety collapse pattern, if properly documented, is the most novel result.** The sharp spike in hallucination rates from ~2–3% at 1.7B to 18–75% below 360M parameters (Table 3) is a concrete finding that could guide deployment decisions.

## Weaknesses

### Fatal

None.

### Major

1. **Central claim rests on an asymmetric comparison (fine-tuned small vs. ICL-only large).** The paper's headline contribution — that "multiple small models not only reach but occasionally exceed the performance of much larger medical LLMs" (abstract, line 17) and that "all small LMs outperformed large LMs across all metrics" (lines 231, 247) — compares **LoRA-fine-tuned small LMs** against **large LMs evaluated only with in-context learning (zero/few-shot)**. Figure 3 makes this explicit: large models (BioMistral, Med-LLaMA, OpenBioLLM) have `-` in the LoRA column; only small models were fine-tuned. The paper compares things that differ in *two* ways — model size *and* adaptation method — and attributes the difference entirely to size. The paper's own zero-shot results (Table 2) are the only fair comparison, and they tell a modest story: only SmolLM2 is competitive; LLaMA-3.2 and Gemma-3 trail across nearly all metrics. The fine-tuning results are still interesting (LoRA-tuned 1B models can match zero-shot 8B models) but need honest reframing. This requires no new experiments — just accurate characterization of the comparison.

2. **Collapse Analysis metrics are never defined, making Table 3 uninterpretable.** The paper's most distinctive claimed contribution is the "Collapse Analysis" across Task Adherence, Hallucination Rate, Concept Recall, Prompt Robustness, and the composite Readiness Score (Table 3, lines 122–132). These metrics are the basis for the "safety collapse" finding and the "Pareto-optimality" claim at 1B. However, the paper *never specifies how any of these metrics are computed*. Are they human evaluations? Automated scoring against a rubric? LLM-as-judge? If automated, what algorithm? What reference standard? No definition, annotation protocol, inter-annotator agreement, or computational procedure is provided. Without this information, Table 3 is an opaque table of numbers that cannot be evaluated, reproduced, or trusted. This is not a minor clarity issue — it means the paper's most novel finding is not verifiable as submitted.

3. **Same asymmetry in the VLM comparison.** After fine-tuning small VLMs (Florence 2, Qwen 2.5-VL) on 10K MIMIC-CXR pairs and comparing them against Med-Flamingo (9B) and LLaVA-Med (7B), the paper never states whether the large VLMs were also fine-tuned or evaluated zero-shot (lines 219–225). Table 4 reports scores for all four models, but without knowing the evaluation setup for the large VLMs, the comparison has the same fairness ambiguity. (The directional conclusion — small fine-tuned < large — would still be informative, but the gap could be smaller or larger depending on the large models' setup.)

### Minor

4. **No uncertainty quantification.** All results in Tables 2, 3, and 4 are point estimates with no confidence intervals, standard deviations, or significance tests. With 250 test samples, many reported differences are small (e.g., BERTScore 0.9007 vs. 0.8938 in Table 2, MEDCON differences of 0.02–0.04). The paper makes comparative claims without indicating whether differences are within the noise floor.

5. **Missing reproducibility details.** Several specifics are absent: (a) fine-tuning hyperparameters — LoRA rank, alpha, learning rate, batch size, epochs, training/validation split; (b) the five prompt templates used for zero-shot evaluation (only one example instruction is shown in Table 2); (c) the total size of MeQSum and how many samples were used for training; (d) the term "MeQ-Small corpus" (line 231) appears without definition.

6. **VLM large-model setup not stated.** As noted in Major #3, the paper should explicitly state whether Med-Flamingo and LLaVA-Med were fine-tuned on the same 10K split, used zero-shot, or something else.

### Trivial

None.

## Nice-to-Haves

- Adding bootstrap confidence intervals on the 250 test samples would help distinguish signal from noise.
- Reporting per-prompt variance for zero-shot results would reveal prompt sensitivity differences across models.
- A single comparison of a LoRA-tuned large model against LoRA-tuned small models would resolve the fairness question.
- Reporting the training dataset size for MeQSum fine-tuning.

## Removed Points

- **MedGemini/MedPaLM2 not in evaluation**: The paper mentions these in the introduction (line 13) as examples of large medical LLMs to motivate the question, not as experimental baselines. This is standard framing, not a flaw.
- **"Odd passage" about physicians preferring larger models**: The paper's caveat (lines 48–52) that automated metrics do not fully capture clinical preference is an honest scope boundary that strengthens, not undermines, the paper's positioning. The reviewer mischaracterized this.
- **"Table ??" typo**: Likely a parser artifact; even if a formatting issue, it is minor and not substantive.
- **Decoding strategy sensitivity analysis**: Requesting sensitivity analysis on top-p/temperature/k is a nice-to-have, not a core flaw.
- **Pareto-optimality formalism**: While technically valid, this is secondary to the larger issues of asymmetric comparison and undefined metrics.
- **Limitations section not mentioning unfair comparison**: Subsumed by Major #1 — the unfair comparison itself is the issue.

## Novel Insights

The reviews converge on the observation that the paper's claimed superiority of small LMs over large LMs is actually a claim about **LoRA efficiency vs. zero-shot capability** — a more precise and modest finding that is still practically useful. The collapse analysis framework is conceptually promising but methodologically incomplete; the metrics need operational definitions before the safety collapse threshold can be accepted as evidence. The paper's genuine contributions are better captured by a contrastive framing (text vs. vision, zero-shot vs. fine-tuned) than by the "small beats large" narrative.

## Suggestions

1. **Restructure the headline claim** from "small models match or exceed large ones" to something precise such as: "For clinical text summarization, LoRA fine-tuning a 1B model on the target task matches or exceeds zero-shot performance of 8B medically-pretrained models; for radiology report generation, small VLMs remain inferior even after fine-tuning." This requires no new experiments.
2. **Define every Collapse Analysis metric** — state whether they are human-rated or automated, provide the annotation protocol or scoring algorithm, and report inter-annotator agreement if human.
3. **Add variance estimates** (bootstrap CIs or standard deviations) to all tables.
4. **Specify the large VLMs' evaluation setup** in the VLM experiments.
5. **Report all missing hyperparameters** and list the five prompt templates.

## Score and Decision

MY FINAL SCORE: <score>4.0</score>
MY FINAL DECISION: <decision>Reject</decision>